Aduro (ADRO) Q3 Loss Wider Than Expected, Revenues Rise Y/Y

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Merck & Co., Inc. (MRK): Free Stock Analysis Report
 
Novartis AG (NVS): Free Stock Analysis Report
 
Eli Lilly and Company (LLY): Free Stock Analysis Report
 
Aduro Biotech, Inc. (ADRO): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research
Zacks Investment Research – All Commentary Articles

Pin It